GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Traphaco JSC (STC:TRA) » Definitions » Capex-to-Operating-Income

Traphaco JSC (STC:TRA) Capex-to-Operating-Income : 0.69 (As of Mar. 2025)


View and export this data going back to 2008. Start your Free Trial

What is Traphaco JSC Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Traphaco JSC's Capital Expenditure for the three months ended in Mar. 2025 was â‚«-38,907.70 Mil. Its Operating Income for the three months ended in Mar. 2025 was â‚«56,069.83 Mil.

Hence, Traphaco JSC's Capex-to-Operating-Income for the three months ended in Mar. 2025 was 0.69.


Traphaco JSC Capex-to-Operating-Income Historical Data

The historical data trend for Traphaco JSC's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Traphaco JSC Capex-to-Operating-Income Chart

Traphaco JSC Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.10 0.17 0.30 0.28

Traphaco JSC Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.28 0.52 0.18 0.69

Competitive Comparison of Traphaco JSC's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Traphaco JSC's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Traphaco JSC's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Traphaco JSC's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Traphaco JSC's Capex-to-Operating-Income falls into.


;
;

Traphaco JSC Capex-to-Operating-Income Calculation

Traphaco JSC's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-86671.274) / 306455.273
=0.28

Traphaco JSC's Capex-to-Operating-Income for the quarter that ended in Mar. 2025 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-38907.699) / 56069.833
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Traphaco JSC  (STC:TRA) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Traphaco JSC Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Traphaco JSC's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Traphaco JSC Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Traphaco JSC (STC:TRA) » Definitions » Capex-to-Operating-Income
Traded in Other Exchanges
N/A
Address
75 Yen Ninh Street, Ba Dinh District, Ha Noi City, VNM
Traphaco JSC is engaged in the manufacturing and trading of pharmaceutical products, chemicals and medical supplies and equipment. The company's products include abfuco; amorvita multi; ampelop; aspirin; cagu and amongst others.

Traphaco JSC Headlines

No Headlines